Deciphera Pharmaceuticals Inc (DCPH.OQ)
DCPH.OQ on NASDAQ Stock Exchange Global Select Market
27.23USD
18 Oct 2018
27.23USD
18 Oct 2018
Change (% chg)
$-1.42 (-4.96%)
$-1.42 (-4.96%)
Prev Close
$28.65
$28.65
Open
$28.59
$28.59
Day's High
$28.59
$28.59
Day's Low
$27.02
$27.02
Volume
77,425
77,425
Avg. Vol
59,419
59,419
52-wk High
$45.61
$45.61
52-wk Low
$15.37
$15.37
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 0.00 | -0.646 |
| Mar '18 | 0.00 | -0.657 | |
| FY 2017 | Dec '17 | 0.00 | -0.649 |
| Sep '17 | 0.00 | -0.392 | |
| Jun '17 | 0.00 | -0.346 | |
| Mar '17 | 0.00 | -0.251 | |
| FY 2016 | Dec '16 | 0.00 | -0.279 |
| Sep '16 | 0.00 | -2.964 | |
| Jun '16 | 0.00 | -0.193 | |
| Mar '16 | 0.00 | -0.174 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 11 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Mar-19 | 7 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 12 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-19 | 12 | 8.33 | 100.00 | 0.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 11 | -0.71 | -0.63 | -0.82 | -- |
| Quarter Ending Mar-19 | 5 | -0.75 | -0.63 | -0.87 | -- |
| Year Ending Dec-18 | 12 | -2.63 | -2.30 | -2.85 | -- |
| Year Ending Dec-19 | 12 | -2.82 | -0.19 | -3.67 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 85.83 | 33.69 | |
| P/E High - Last 5 Yrs. | -- | 288.76 | 45.21 | |
| P/E Low - Last 5 Yrs. | -- | 90.17 | 23.79 | |
| Beta | -- | 0.93 | 0.88 | |
| Price to Sales (TTM) | -- | 123.60 | 5.82 | |
| Price to Book (MRQ) | -- | 15.31 | 4.89 | |
| Price to Tangible Book (MRQ) | 8.04 | 14.52 | 6.52 | |
| Price to Cash Flow (TTM) | -- | 70.45 | 22.95 | |
| % Owned Institutions | -- | 14.08 | 2.14 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.33 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.24 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 2.55 | 5.39 | |
| Payout Ratio(TTM) | -- | 16.83 | 43.91 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 413.48 | 8.02 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 103.91 | 5.75 | |
| Sales - 5 Yr. Growth Rate | -- | 30.81 | 9.88 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -79.11 | 24.33 | 23.65 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -- | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 37.81 | 10.95 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 38.61 | 14.90 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.94 | 2.25 |
| Current Ratio (MRQ) | 11.53 | 5.34 | 3.05 |
| LT Debt to Equity (MRQ) | 1.59 | 34.95 | 12.73 |
| Total Debt to Equity (MRQ) | 1.80 | 36.76 | 17.15 |
| Interest Coverage (TTM) | -- | -97.17 | 37.58 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 40.15 | 54.90 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.21 | 52.43 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -575.88 | 11.08 | |
| Operating Margin (TTM) | -- | -770.08 | 4.31 | |
| Operating Margin - 5 Yr. Avg. | -- | -596.20 | 6.43 | |
| Pre-Tax Margin (TTM) | -- | -732.14 | 5.36 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -601.79 | 6.86 | |
| Net Profit Margin (TTM) | -- | -733.08 | 1.64 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -604.76 | 3.11 | |
| Effective Tax Rate (TTM) | -- | 23.64 | 23.24 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.79 | 24.16 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 22,788,701 | 810,573,943 | |
| Net Income/Employee (TTM) | -- | 1,717,126 | 95,338,757 | |
| Receivable Turnover (TTM) | -- | 19.81 | 5.77 | |
| Inventory Turnover (TTM) | -- | 2.38 | 3.62 | |
| Asset Turnover (TTM) | -- | 0.40 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | -1.09 | 10.92 | |
| Return on Assets - 5 Yr. Avg. | -- | 3.20 | 12.03 | |
| Return on Investment (TTM) | -- | 0.58 | 14.30 | |
| Return on Investment - 5 Yr. Avg. | -- | 2.28 | 15.63 | |
| Return on Equity (TTM) | -- | 1.62 | 16.03 | |
| Return on Equity - 5 Yr. Avg. | -- | 3.07 | 16.90 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -30.90 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Deciphera Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -- | -- | -- | 59 |
| 13 Week | -- | -- | -- | 63 |
| 26 Week | -- | -- | -- | 76 |
| 52 Week | -- | -- | -- | 47 |
| YTD | -- | -- | -- | 57 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 54.76% |
| # of Holders: | 120 |
| Total Shares Held: | 20,622,866 |
| 3 Mo. Net Change: | 103,861 |
| # New Positions: | 1 |
| # Closed Positions: | 0 |
| # Increased Positions: | 9 |
| # Reduced Positions: | 3 |
| # Net Buyers: | 6 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.